Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.41 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.39 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.35 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PTAFR | P25105 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134194 | 0.89 | — | — | |
| SCHEMBL8162675 | 0.88 | CES1 (0.61) | CES1MAOBMAOACYP2A6L3MBTL1 | |
| SCHEMBL4312831 | 0.87 | CES1 (0.46) | CES1SETD7SRD5A1SRD5A2MAOB | |
| SCHEMBL24657 | 0.83 | MAOA (0.46) | CES1SRD5A2MAOBMAOANPC1 | |
| SCHEMBL4824206 | 0.80 | — | — | |
| Dihydrophenanthrene SCHEMBL30297028 | 0.78 | CES1 (0.68) | CES1SETD7SRD5A1SRD5A2MAOB | |
| Dihydrophenanthrene SCHEMBL155991 | 0.78 | CES1 (0.68) | CES1SETD7SRD5A1SRD5A2MAOB | |
| Dihydrophenanthrene SCHEMBL29404495 | 0.78 | CES1 (0.68) | CES1SETD7SRD5A1SRD5A2MAOB | |
| SCHEMBL8911202 | 0.78 | CA12 (0.38) | MAOBMAOAPARP1 | |
| SCHEMBL8174906 | 0.76 | CES1 (0.61) | CES1MAOBMAOACYP2A6L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113109960-A | Horizontal alignment liquid crystal display element, liquid crystal composition, display device, and method for manufacturing horizontal alignment liquid crystal display element | 捷恩智株式会社 | 2021-07-13 | — | — | CN | claimed |
| CN-112538358-A | Horizontal alignment liquid crystal display element, liquid crystal composition, display device, and method for manufacturing horizontal alignment liquid crystal display element | 捷恩智株式会社 | 2021-03-23 | — | — | CN | claimed |
| EP-1334117-B1 | ANTIBACTERIAL AGENTS COMPRISING CONJUGATES OF GLYCOPEPTIDES AND PEPTIDIC MEMBRANE-ASSOCIATING ELEMENTS | CAMBRIDGE ENTPR LTD (GB) | 2012-02-01 | — | — | EP | claimed |
| US-7078380-B2 | Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-07-18 | — | — | US | claimed |
| US-20040106544-A1 | Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements | CAMBRIDGE ENTERPRISE LTD. (GB) | 2004-06-03 | — | — | US | claimed |
| EP-1334117-A1 | ANTIBACTERIAL AGENTS COMPRISING CONJUGATES OF GLYCOPEPTIDES AND PEPTIDIC MEMBRANE-ASSOCIATING ELEMENTS | Cambridge University Technical Services Limited (GB) | 2003-08-13 | — | — | EP | claimed |
| WO-2002036612-A1 | ANTIBACTERIAL AGENTS COMPRISING CONJUGATES OF GLYCOPEPTIDES AND PEPTIDIC MEMBRANE-ASSOCIATING ELEMENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2002-05-10 | — | — | WO | claimed |
| EP-0816378-B1 | Glycopeptide antibiotic amide derivatives | LILLY CO ELI (US) | 2002-04-10 | — | — | EP | claimed |
| US-5919756-A | CHLORORIENTICIN A ANTIBIOTIC | ELI LILLY AND COMPANY (US) | 1999-07-06 | — | — | US | claimed |
| WO-1998000153-A1 | AMIDES | ELI LILLY AND COMPANY (US) | 1998-01-08 | — | — | WO | claimed |
| EP-0816378-A1 | Glycopeptide antibiotic amide derivatives | ELI LILLY AND COMPANY (US) | 1998-01-07 | — | — | EP | claimed |
| EP-0194764-B1 | PESTICIDAL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1989-07-12 | — | — | EP | claimed |
| EP-0194764-A1 | Pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-09-17 | — | — | EP | claimed |
| CN-113109960-A | Horizontal alignment liquid crystal display element, liquid crystal composition, display device, and method for manufacturing horizontal alignment liquid crystal display element | 捷恩智株式会社 | 2021-07-13 | — | — | CN | disclosed |
| CN-112538358-A | Horizontal alignment liquid crystal display element, liquid crystal composition, display device, and method for manufacturing horizontal alignment liquid crystal display element | 捷恩智株式会社 | 2021-03-23 | — | — | CN | disclosed |
| EP-1879873-B1 | NEUROTHERAPEUTIC AZOLE COMPOUNDS | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-10-09 | — | — | EP | disclosed |
| WO-1998000153-A1 | AMIDES | ELI LILLY AND COMPANY (US) | 1998-01-08 | — | — | WO | disclosed |
| EP-0816378-A1 | Glycopeptide antibiotic amide derivatives | ELI LILLY AND COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0702015-B1 | Bicyclic oxazole and thiazole substituted ethers | CIBA GEIGY AG (CH) | 1997-09-24 | — | — | EP | disclosed |
| EP-0702015-A1 | Bicyclic oxazole and thiazole substituted ethers | SANDOZ LTD. (CH) | 1996-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106544-A1 | Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements | VMA21, VIP, MLX | CES1 3897/4885SETD7 4535/4885SRD5A1 4696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.